These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35546671)

  • 1. Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B.
    Murcko R; Marchi N; Bailey D; Janigro D
    Fluids Barriers CNS; 2022 May; 19(1):32. PubMed ID: 35546671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers.
    Dadas A; Washington J; Marchi N; Janigro D
    Fluids Barriers CNS; 2016 Nov; 13(1):21. PubMed ID: 27903281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is peripheral immunity regulated by blood-brain barrier permeability changes?
    Bargerstock E; Puvenna V; Iffland P; Falcone T; Hossain M; Vetter S; Man S; Dickstein L; Marchi N; Ghosh C; Carvalho-Tavares J; Janigro D
    PLoS One; 2014; 9(7):e101477. PubMed ID: 24988410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
    Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
    J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modelling of serum S100b after traumatic brain injury.
    Ercole A; Thelin EP; Holst A; Bellander BM; Nelson DW
    BMC Neurol; 2016 Jun; 16():93. PubMed ID: 27315805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury.
    Gayger-Dias V; Vizuete AF; Rodrigues L; Wartchow KM; Bobermin L; Leite MC; Quincozes-Santos A; Kleindienst A; Gonçalves CA
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2109-2119. PubMed ID: 38058025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracranial sources of S100B do not affect serum levels.
    Pham N; Fazio V; Cucullo L; Teng Q; Biberthaler P; Bazarian JJ; Janigro D
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction.
    Gulati G; Iffland PH; Janigro D; Zhang B; Luggen ME
    Clin Rheumatol; 2016 Dec; 35(12):2989-2997. PubMed ID: 27357716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B as a marker for brain damage and blood-brain barrier disruption following exercise.
    Koh SX; Lee JK
    Sports Med; 2014 Mar; 44(3):369-85. PubMed ID: 24194479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.
    Filippidis AS; Papadopoulos DC; Kapsalaki EZ; Fountas KN
    Neurosurg Focus; 2010 Nov; 29(5):E2. PubMed ID: 21039136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
    Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
    J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [S100B protein serum level as a biomarker of minor head injury].
    Beaudeux JL; Laribi S
    Ann Biol Clin (Paris); 2013 Nov; 71():71-8. PubMed ID: 24235330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S100B story: from biomarker to active factor in neural injury.
    Michetti F; D'Ambrosi N; Toesca A; Puglisi MA; Serrano A; Marchese E; Corvino V; Geloso MC
    J Neurochem; 2019 Jan; 148(2):168-187. PubMed ID: 30144068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.
    Gonzćlez-Mao MC; Repáraz-Andrade A; Del Campo-Pérez V; Alvarez-García E; Vara-Perez C; Andrade-Olivié MA
    Clin Lab; 2011; 57(7-8):587-97. PubMed ID: 21888023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of S100B/RAGE-enhanced ADAM17 activation in endothelial glycocalyx shedding after traumatic brain injury.
    Zou Z; Li L; Li Q; Zhao P; Zhang K; Liu C; Cai D; Maegele M; Gu Z; Huang Q
    J Neuroinflammation; 2022 Feb; 19(1):46. PubMed ID: 35148784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum glial fibrillary acidic protein and S100B serum levels in emergency medicine patients with traumatic versus nontraumatic intracerebral hemorrhage.
    Aydin I; Algin A; Poyraz MK; Yumrutas O
    Niger J Clin Pract; 2018 Dec; 21(12):1645-1650. PubMed ID: 30560830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.
    Amoo M; Henry J; O'Halloran PJ; Brennan P; Husien MB; Campbell M; Caird J; Javadpour M; Curley GF
    Neurosurg Rev; 2022 Apr; 45(2):1171-1193. PubMed ID: 34709508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.